漱玉平民(301017.SZ):目前暫未開展醫療美容相關業務
格隆匯8月8日丨漱玉平民(301017.SZ)在互動平台表示,公司目前暫未開展醫療美容相關業務,當前主要銷售的健康美麗產品包括功能性護膚品、口服抗衰產品等。在業務佈局上,公司已成立健康美麗事業部,攜手中歐院士凌沛學團隊合作開展透明質酸多元化應用產品矩陣,與循證醫學院聯合打造PDRN抗衰系列產品,同時與曾獲“全球重組膠原蛋白銷量第一”的頭部工廠共同開發分子肌蜜高端護膚產品。未來,公司將始終以顧客需求為導向,持續優化商品品類,力求為顧客提供更優質的服務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.